Dr. Reddy's Laboratories Limited (RDY)
NYQ – Real vaqt narxi. Valyuta: USD
15.38
+0.13 (0.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
15.32
-0.06 (-0.39%)
Bozordan keyin: Jun 26, 2026, 6:40 PM EDT
Find any stock by ticker or company name

NYQ – Real vaqt narxi. Valyuta: USD
15.38
+0.13 (0.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
15.32
-0.06 (-0.39%)
Bozordan keyin: Jun 26, 2026, 6:40 PM EDT
Dr. Reddy's Laboratories Limited o'z sho'ba korxonalari bilan birgalikda Shimoliy Amerika, Yevropa, Hindiston, Rossiya va xalqaro miqyosda integratsiyalashgan farmatsevtika kompaniyasi sifatida faoliyat yuritadi. Kompaniya Global Generics, Pharmaceutical Services and Active Ingredients (PSAI) va Boshqalar segmentlari orqali ishlaydi. Global Generics segmenti retsept bo'yicha va retseptsiz tayyor farmatsevtika mahsulotlarini ishlab chiqaradi va sotadi, ular brend nomi ostida yoki brendli preparatlarga terapevtik ekvivalent bo'lgan tayyor generik dozalar sifatida sotiladi, shuningdek, biologik preparatlar biznesi bilan shug'ullanadi. PSAI segmenti faol farmatsevtika tarkibiy qismlari va oraliq mahsulotlarni ishlab chiqaradi va sotadi, ular tayyor farmatsevtika mahsulotlarining asosiy tarkibiy qismlaridir. Ushbu segment shuningdek, shartnoma tadqiqot xizmatlarini taqdim etadi; va mijoz talablariga muvofiq faol farmatsevtika tarkibiy qismlari va steroidlarni ishlab chiqaradi va sotadi. Boshqalar segmenti onkologiya va yallig'lanish sohalarida terapiyalarni ishlab chiqish; hamda differentsiatsiyalangan formulalarni tadqiq qilish, ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Kompaniya o'z mahsulotlarini turli terapevtik toifalarga, jumladan, oshqozon-ichak, yurak-qon tomir, diabetga qarshi, dermatologiya, onkologiya, respirator, stomatologiya, urologiya va nefrologiya, vaktsinalar, vitaminlar va minerallar, hamda og'riqni boshqarish uchun taklif etadi. Dr. Reddy's Laboratories Limited 1984 yilda tashkil etilgan va shtab-kvartirasi Haydarobod, Hindistonda joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Bhethanabottla S. Phanimitra | Chief Digital & Information Officer and Member of the Management Council |
| Mr. Deepak Sapra M.B.A. | Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Council |
| Mr. Erez Israeli M.B.A. | CEO & Member of the Management Council |
| Mr. Gunupati Venkateswara Prasad B.E. | Co-Chairman, MD & Member of Management Council |
| Mr. Kallam Satish Reddy B.Tech., M.S. | Chairman of the Board & Member of the Management Council |
| Mr. Krishna K. Venkatesh B.Pharma M.S. | Global Head of IPDO, Integrated Product Development & Member of the Management Council |
| Mr. Mannam Venkatanarasimham | CFO & Member of the Management Council |
| Mr. Motupalli Venkata Ramana M.B.A. | CEO of Global Generics & Member of Management Council |
| Mr. Patrick Aghanian B.A., M.B.A. | Head of Consumer Health Organization & Member of Management Council |
| Mr. Sanjay Sharma B.Tech. | Executive VP, COO & Member of Management Council |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-26 | 6-K | rdy0911_6k.htm |
| 2026-06-22 | 6-K | rdy0909_6k.htm |
| 2026-06-15 | 6-K | rdy0907_6k.htm |
| 2026-06-10 | 6-K | rdy0906_6k.htm |
| 2026-06-05 | 6-K | rdy0905_6k.htm |
| 2026-06-03 | 6-K | rdy0904_6k.htm |
| 2026-06-01 | 6-K | rdy902_6k.htm |
| 2026-05-29 | 20-F | rdy0899_20f.htm |
| 2026-05-28 | 6-K | rdy900_6k.htm |
| 2026-05-18 | 6-K | rdy0898_6k.htm |